Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
1. Fresenius Medical Care expands High-Volume Hemodiafiltration access in Mexico. 2. 240 new patients received High-Volume Hemodiafiltration treatment. 3. Fresenius aims to introduce this therapy in the U.S. market. 4. High-Volume Hemodiafiltration has shown a 23% mortality reduction. 5. FDA cleared 5008X CAREsystem for U.S. commercialization by 2026.